Detailed view for PF3D7_0113800

Basic information

TDR Targets ID: 3252
Plasmodium falciparum, DBL containing protein, unknown function

Source Database / ID:  PlasmoDB   |   GeneDB   |   MPMP

pI: 5.0901 | Length (AA): 2900 | MW (Da): 346566 | Paralog Number: 0

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0

Druggability Group : DG1

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF05424   Duffy binding domain

Gene Ontology

Mouse over links to read term descriptions.
GO:0046789   host cell surface receptor binding  
GO:0016021   integral to membrane  
GO:0004872   receptor activity  
GO:0009405   pathogenesis  

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

There are 28 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
654 1335 1zro (A) 15 600 26.00 0 1 0.23 0.89
340 534 4uos (A) 2 184 19.00 0.5 0.48 0.315241 -1.26
556 1237 2yk0 (A) 19 715 14.00 0 0.86 0.149172 1.06
622 1316 4p1t (A) 1218 1904 24.00 0 1 0.150655 1.03
649 945 3rrc (A) 215 507 22.00 0.0000000000055 1 0.288414 -0.42
658 943 4nuu (A) 213 505 23.00 0 1 0.385421 -0.68
797 907 4v3e (A) 532 644 33.00 0.4 0.09 0.122376 0.25
949 1568 2yk0 (A) 27 713 20.00 0 1 0.162593 0.9
1009 1311 2y8d (A) 2331 2597 37.00 0 1 0.335583 -0.11
1036 1334 4nuu (A) 210 508 23.00 0.000000000011 1 0.347103 -0.5
1047 1383 2yk0 (A) 117 513 31.00 0 1 0.231307 0.25
1945 2162 1yo8 (A) 717 961 32.00 0.00000021 0.12 0.0862724 0.01
2024 2159 1ux6 (A) 816 938 30.00 0.029 0.07 0.265997 -1.12
2555 2744 4uos (A) 1 183 22.00 0.0014 0.29 0.399317 -1.46
2572 2757 4tql (A) 18 201 25.00 0.47 0.57 0.332238 -0.61
3 570 3s5h (A) 348 997 19.00 0.00055 0.74 -0.0271128 1.7
275 457 4uos (A) 2 185 20.00 0.22 0.56 0.268993 -0.86
622 1329 4p1t (A) 1218 1915 24.00 0 1 0.155849 1.11
655 945 4nuu (A) 210 505 22.00 0 1 0.341892 -0.49
797 935 4v3e (A) 532 672 30.00 0.33 0.06 0.158619 0.15
958 1592 2yk0 (A) 34 712 19.00 0 1 0.22274 0.78
990 1335 2xu0 (A) 27 469 27.00 0 1 0.255734 -0.04
1033 1318 3vuu (A) 162 454 35.00 0 1 0.281979 0.66
1045 1344 2wau (A) 2350 2634 28.00 0 1 0.357975 -0.22
1966 2100 1ux6 (A) 820 958 27.00 0.024 0.01 0.376249 -1.09
1996 2265 1yo8 (A) 725 968 28.00 0.0000003 0.02 0.143497 0.51
2560 2752 4uos (A) 1 183 22.00 0.00047 0.14 0.336319 -1.23
2577 2776 4tql (A) 18 201 25.00 0.38 0.69 0.264517 -0.37

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

  • 1ZRL:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 1ZRO:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 2WAU:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 2XU0:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 2Y8D:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 2YK0:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 3BQI:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 3BQK:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 3BQL:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 3CML:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 3CPZ:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 3VUU:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 3VUV:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 4GF2:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 4JNO:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 4P1T:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 4QEX:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 5MZA:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date

Expression

Upregulation Percent Ranking Stage Dataset
Upper 80-100% percentile Sporozoite. Zanghi G
Upregulation Percent Ranking Stage Dataset
Mid 40-60% percentile intra-erythrocytic - 16 hs, Ring. Otto TD Zanghi G
Upregulation Percent Ranking Stage Dataset
Lower 20-40% percentile intra-erythrocytic - 8 hs. Otto TD
Upregulation Percent Ranking Stage Dataset
Lower 0-20% percentile intra-erythrocytic - 0 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Oocyst, Female Gametocyte, Male Gametocyte. Otto TD Zanghi G Lasonder E
Show/Hide expression data references
  • Zanghi G A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection.
  • Otto TD New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq.
  • Lasonder E Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression.

Orthologs

Ortholog group members (OG5_197688)

Species Accession Gene Product
Plasmodium falciparum PF3D7_0113800   DBL containing protein, unknown function

Essentiality

No essentiality data collected for this gene and/or its orthologs.

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.


Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets

Obtained from network model
No druggable targets predicted through repurposing network model

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier PF3D7_0113800 (Plasmodium falciparum), DBL containing protein, unknown function
Title for this comment
Comment